BCR–ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy

समान संसाधन

• BCR-ABL–specific T-cell therapy in Ph(+) ALL patients on tyrosine-kinase inhibitors
  द्वारा: Comoli, Patrizia, और अन्य
  प्रकाशित: (2017)
• β-HHVs and HHV-8 in Lymphoproliferative Disorders
  द्वारा: Quadrelli, C., और अन्य
  प्रकाशित: (2011)
• Pathogenetic Mechanisms of Hepatitis C Virus-Induced B-Cell Lymphomagenesis
  द्वारा: Forghieri, Fabio, और अन्य
  प्रकाशित: (2012)
• Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives
  द्वारा: Forghieri, Fabio, और अन्य
  प्रकाशित: (2018)
• All‐trans retinoic acid (ATRA) in non‐promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low‐dose Ara‐C in three elderly patients with NPM1‐mutated AML unfit for intensive chemotherapy and review of the literature
  द्वारा: Forghieri, Fabio, और अन्य
  प्रकाशित: (2016)